vs
Side-by-side financial comparison of Karyopharm Therapeutics Inc. (KPTI) and Northfield Bancorp, Inc. (NFBK). Click either name above to swap in a different company.
Northfield Bancorp, Inc. is the larger business by last-quarter revenue ($41.3M vs $34.1M, roughly 1.2× Karyopharm Therapeutics Inc.). Karyopharm Therapeutics Inc. runs the higher net margin — -299.9% vs -1545.5%, a 1245.6% gap on every dollar of revenue. On growth, Northfield Bancorp, Inc. posted the faster year-over-year revenue change (12.7% vs 11.6%). Over the past eight quarters, Northfield Bancorp, Inc.'s revenue compounded faster (15.0% CAGR vs 1.4%).
Northfield Bancorp, Inc. is a regional bank holding company based in the United States, operating primarily across the U.S. Northeast region. It provides a full range of personal and commercial banking services including deposit accounts, mortgage loans, commercial lending, and wealth management solutions for retail consumers, small to medium-sized businesses and local community clients.
KPTI vs NFBK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $34.1M | $41.3M |
| Net Profit | $-102.2M | $-27.4M |
| Gross Margin | — | — |
| Operating Margin | -52.4% | -1263.3% |
| Net Margin | -299.9% | -1545.5% |
| Revenue YoY | 11.6% | 12.7% |
| Net Profit YoY | -232.0% | -343.6% |
| EPS (diluted) | $-7.02 | $-0.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $34.1M | $41.3M | ||
| Q3 25 | $44.0M | $39.2M | ||
| Q2 25 | $37.9M | $38.9M | ||
| Q1 25 | $30.0M | $34.8M | ||
| Q4 24 | $30.5M | $36.7M | ||
| Q3 24 | $38.8M | $31.8M | ||
| Q2 24 | $42.8M | $31.5M | ||
| Q1 24 | $33.1M | $31.3M |
| Q4 25 | $-102.2M | $-27.4M | ||
| Q3 25 | $-33.1M | $10.8M | ||
| Q2 25 | $-37.3M | $9.6M | ||
| Q1 25 | $-23.5M | $7.9M | ||
| Q4 24 | $-30.8M | $11.3M | ||
| Q3 24 | $-32.1M | $6.5M | ||
| Q2 24 | $23.8M | $6.0M | ||
| Q1 24 | $-37.4M | $6.2M |
| Q4 25 | -52.4% | -1263.3% | ||
| Q3 25 | -34.6% | 37.7% | ||
| Q2 25 | -64.3% | 35.6% | ||
| Q1 25 | -110.8% | 31.0% | ||
| Q4 24 | -102.4% | 38.0% | ||
| Q3 24 | -67.8% | 27.9% | ||
| Q2 24 | -65.7% | 29.1% | ||
| Q1 24 | -101.9% | 27.2% |
| Q4 25 | -299.9% | -1545.5% | ||
| Q3 25 | -75.2% | 27.4% | ||
| Q2 25 | -98.2% | 24.6% | ||
| Q1 25 | -78.2% | 22.6% | ||
| Q4 24 | -100.8% | 30.7% | ||
| Q3 24 | -82.7% | 20.5% | ||
| Q2 24 | 55.6% | 18.9% | ||
| Q1 24 | -112.8% | 19.9% |
| Q4 25 | $-7.02 | $-0.68 | ||
| Q3 25 | $-3.82 | $0.27 | ||
| Q2 25 | $-4.32 | $0.24 | ||
| Q1 25 | $-2.77 | $0.19 | ||
| Q4 24 | $-2.33 | $0.27 | ||
| Q3 24 | $-3.85 | $0.16 | ||
| Q2 24 | $-2.97 | $0.14 | ||
| Q1 24 | $-4.85 | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $60.5M | $164.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-292.9M | $690.1M |
| Total Assets | $108.4M | $5.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $60.5M | $164.0M | ||
| Q3 25 | $37.7M | $131.7M | ||
| Q2 25 | $38.7M | $97.6M | ||
| Q1 25 | $38.8M | $101.7M | ||
| Q4 24 | $62.5M | $167.7M | ||
| Q3 24 | $72.8M | $232.9M | ||
| Q2 24 | $84.8M | $153.5M | ||
| Q1 24 | $30.6M | $238.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $666.4M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-292.9M | $690.1M | ||
| Q3 25 | $-269.3M | $719.6M | ||
| Q2 25 | $-238.9M | $710.3M | ||
| Q1 25 | $-205.9M | $711.1M | ||
| Q4 24 | $-186.0M | $704.7M | ||
| Q3 24 | $-159.6M | $699.6M | ||
| Q2 24 | $-132.1M | $693.0M | ||
| Q1 24 | $-169.0M | $698.4M |
| Q4 25 | $108.4M | $5.8B | ||
| Q3 25 | $96.2M | $5.7B | ||
| Q2 25 | $104.9M | $5.7B | ||
| Q1 25 | $127.7M | $5.7B | ||
| Q4 24 | $164.4M | $5.7B | ||
| Q3 24 | $189.5M | $5.7B | ||
| Q2 24 | $214.0M | $5.7B | ||
| Q1 24 | $204.5M | $5.9B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.95× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-11.8M | $53.7M |
| Free Cash FlowOCF − Capex | — | $52.5M |
| FCF MarginFCF / Revenue | — | 127.1% |
| Capex IntensityCapex / Revenue | 0.0% | 2.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $89.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-11.8M | $53.7M | ||
| Q3 25 | $-5.9M | $13.9M | ||
| Q2 25 | $-18.7M | $14.1M | ||
| Q1 25 | $-39.0M | $9.4M | ||
| Q4 24 | $-25.8M | $31.1M | ||
| Q3 24 | $-19.5M | $14.0M | ||
| Q2 24 | $-38.5M | $6.9M | ||
| Q1 24 | $-43.7M | $4.2M |
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $13.6M | ||
| Q2 25 | — | $13.9M | ||
| Q1 25 | — | $9.2M | ||
| Q4 24 | $-25.9M | $30.0M | ||
| Q3 24 | — | $13.7M | ||
| Q2 24 | — | $6.7M | ||
| Q1 24 | $-43.9M | $3.8M |
| Q4 25 | — | 127.1% | ||
| Q3 25 | — | 34.6% | ||
| Q2 25 | — | 35.7% | ||
| Q1 25 | — | 26.3% | ||
| Q4 24 | -84.7% | 81.6% | ||
| Q3 24 | — | 43.2% | ||
| Q2 24 | — | 21.1% | ||
| Q1 24 | -132.6% | 12.1% |
| Q4 25 | 0.0% | 2.8% | ||
| Q3 25 | 0.0% | 0.8% | ||
| Q2 25 | 0.0% | 0.6% | ||
| Q1 25 | 0.0% | 0.7% | ||
| Q4 24 | 0.2% | 3.1% | ||
| Q3 24 | 0.0% | 0.7% | ||
| Q2 24 | 0.0% | 0.8% | ||
| Q1 24 | 0.6% | 1.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.29× | ||
| Q2 25 | — | 1.48× | ||
| Q1 25 | — | 1.20× | ||
| Q4 24 | — | 2.76× | ||
| Q3 24 | — | 2.14× | ||
| Q2 24 | -1.62× | 1.16× | ||
| Q1 24 | — | 0.68× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KPTI
| Products | $32.1M | 94% |
| License And Other | $2.0M | 6% |
NFBK
Segment breakdown not available.
